Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-25 4:28 pm Purchase | 2026-02-23 | 13D | Orchestra BioMed Holdings, Inc. OBIO | RTW Investments, LP | 11,942,426 19.700% | 3,636,363 (+43.78%) | Filing History |
| 2026-02-17 08:56 am Purchase | 2025-12-31 | 13G | Zai Lab Limited ZLAB | RTW Investments, LP | 69,590,320 6.300% | 46,676,600 (+203.71%) | Filing History |
| 2026-02-17 08:54 am Purchase | 2025-12-31 | 13G | Verastem, Inc. VSTM | RTW Investments, LP | 7,836,346 9.900% | 2,209,543 (+39.27%) | Filing History |
| 2026-02-17 08:52 am Sale | 2025-12-31 | 13G | uniQure N.V. QURE | RTW Investments, LP | 3,711,462 6.000% | -713,506 (-16.12%) | Filing History |
| 2026-02-17 08:51 am Purchase | 2025-12-31 | 13G | Tenax Therapeutics, Inc. TENX | RTW Investments, LP | 650,968 9.900% | 232,528 (+55.57%) | Filing History |
| 2026-02-17 08:49 am Sale | 2025-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 23,407,133 8.300% | -1,776,154 (-7.05%) | Filing History |
| 2026-02-17 08:47 am Purchase | 2025-12-31 | 13G | SAB Biotherapeutics, Inc. SABS | RTW Investments, LP | 1,587,302 3.200% | 562,967 (+54.96%) | Filing History |
| 2026-02-17 08:45 am Purchase | 2025-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | RTW Investments, LP | 1,637,165 5.900% | 1,637,165 (New Position) | Filing History |
| 2026-02-17 08:43 am Purchase | 2025-12-31 | 13G | RadNet, Inc. RDNT | RTW Investments, LP | 3,938,500 5.100% | 3,938,500 (New Position) | Filing History |
| 2026-02-17 08:41 am Sale | 2025-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | RTW Investments, LP | 5,059,053 8.100% | -256,461 (-4.82%) | Filing History |
| 2026-02-17 08:39 am Purchase | 2025-12-31 | 13G | Oruka Therapeutics, Inc. ORKA | RTW Investments, LP | 2,058,148 4.300% | 112,499 (+5.78%) | Filing History |
| 2026-02-17 08:37 am Purchase | 2025-12-31 | 13G | Kalaris Therapeutics Inc KLRS | RTW Investments, LP | 1,300,000 5.700% | 1,300,000 (New Position) | Filing History |
| 2026-02-17 08:35 am Purchase | 2025-12-31 | 13G | Immatics N.V. IMTX | RTW Investments, LP | 11,433,354 8.500% | 2,617,737 (+29.69%) | Filing History |
| 2026-02-17 08:33 am Sale | 2025-12-31 | 13G | Exagen Inc. XGN | RTW Investments, LP | 1,148,768 4.900% | -548,098 (-32.30%) | Filing History |
| 2026-02-17 08:31 am Purchase | 2025-12-31 | 13G | Castle Biosciences, Inc. CSTL | RTW Investments, LP | 2,115,237 7.200% | 2,115,237 (New Position) | Filing History |
| 2026-02-17 08:29 am Sale | 2025-12-31 | 13G | Beta Bionics, Inc. BBNX | RTW Investments, LP | 2,500,000 5.700% | -799,869 (-24.24%) | Filing History |
| 2026-02-17 08:27 am Unchanged | 2025-12-31 | 13G | Apogee Therapeutics, Inc. APGE | RTW Investments, LP | 2,712,097 4.900% | 0 (Unchanged) | Filing History |
| 2026-02-17 08:25 am Purchase | 2025-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | RTW Investments, LP | 7,666,764 6.100% | 7,666,764 (New Position) | Filing History |
| 2026-02-17 08:23 am Sale | 2025-12-31 | 13G | Alector, Inc. ALEC | RTW Investments, LP | 0 0.000% | -6,990,806 (Position Closed) | Filing History |
| 2026-02-17 08:20 am Sale | 2025-12-31 | 13G | Akero Therapeutics, Inc. AKRO | RTW Investments, LP | 0 0.000% | -5,873,308 (Position Closed) | Filing History |